BSX vs. ABT: Which Medical Stock Has More Upside Potential?
BSX vs. ABT: Which Medical Stock Has More Upside Potential? Yahoo Finance
Covered in this story
What has happened since
- Boston Scientific is down 9.0% since this was published, 167 days ago.
- Abbott Laboratories is up 26.1% since this was published, 167 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Boston Scientific
- Truist Securities: at $42.7 · target $51 by Oct 2027 · Buy via Investing.com
- RBC Capital Markets: at $42.7 · target $52 by Oct 2027 · Outperform via Investing.com
- Canaccord Genuity: at $42.7 · target $48 by Oct 2027 · Buy via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $BSX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Boston Scientific →Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.